Teva Pharmaceutical Industries Ltd. ADR 0.52% $23.98B ...

GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Arexvy is an RSV vaccine currently authorised in the US and a further 35 countries. Credit: MargJohnsonVA/Shutterstock. GlaxoSmithKline (GSK) has received approval ...

GSK’sGSK-0.34%decrease; red down pointing triangle blood-cancer drug Blenrep showed positive overall survival data in a late-stage trial, increasing the likelihood for the treatment to return to ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 39,514.80 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...